Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profile of hepatocellular carcinoma with marked immune cell infiltration II

ABSTRACT: Gene expression profile of hepatocellular carcinoma with marked immune cell infiltration II

PROVIDER: PRJNA513314 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Gene expression profile of hepatocellular carcinoma with marked immune cell infiltration II

Project description:Tumor microenvironmental characteristics using gene expression profiles in hepatocellular carcinoma with marked immune stroma (HCC-IS) compared to conventional hepatocellular carcinoma (C-HCC).

2019-06-07 | GSE124752 | GEO

Gene expression profile of hepatocellular carcinoma with marked immune cell infiltration I

Project description:Gene expression profile of hepatocellular carcinoma with marked immune cell infiltration I

| PRJNA513315 | ENA

Gene expression profile of hepatocellular carcinoma with marked immune cell infiltration I

2019-06-07 | GSE124751 | GEO

ZNF207 promotes hepatocellular carcinoma by reprogramming kynurenine metabolism and inhibiting CD8+ T cell infiltration

Project description:ZNF207 promotes hepatocellular carcinoma by reprogramming kynurenine metabolism and inhibiting CD8+ T cell infiltration

| PRJNA705607 | ENA

Luteolin exerts anti-tumor immunity in hepatocellular carcinoma by accelerating CD8+ T lymphocyte infiltration

Project description:Luteolin exerts anti-tumor immunity in hepatocellular carcinoma by accelerating CD8+ T lymphocyte infiltration

| PRJNA1017854 | ENA

WISP2/CCN5 is a prognostic biomarker influenced by tumour purity and fibroblast infiltration in hepatocellular carcinoma

Project description:Background Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide. The dismal outcome is attributable to high frequency of recurrence and metastasis. Therefore, identification of effective biomarkers is a key strategy to inform prognosis and improve survival of HCC patients Methods We analysed expression of WNT-1-induced signalling protein-2 (WISP2) and the prognostic correlation in HCC patients using Oncomine, Kaplan Meier plotter, and Gene Expression Profiling Interactive Analysis 2 (GEPIA2) . We explored the role of WISP2 in HCC using the Cancer Cell Line Encyclopedia (CCLE) and gene microarrays and then assessed the correlation between WISP2 and stromal cells in tumour tissues using the Tumor IMmune Estimation Resource (TIMER). Finally, the role of WISP2 and its relationship with tumour purity and fibroblast infiltration were examined both in vitro and in vivo. Results WISP2 was downregulated in HCC tissues, and high expression of WISP2 was associated with better prognosis in patients with certain clinicopathologic characteristics. Upregulation of WISP2 in HCC was related to inhibition of the malignant phenotype in vitro, but these alterations were not observed in vivo . WISP2 also negatively correlated with tumour purity, and increased infiltration of fibroblasts promoted malignant progression in HCC tissues. The enhanced infiltration ability of fibroblasts was related to upregulated high-mobility group protein 1 (HMGB1) after overexpression of WISP2 in HCC. Conclusions The findings shed light on the anticancer role of WISP2 in HCC, suggest that WISP2 overexpression may serve as a biomarker for better prognosis, and indicate that WISP2 expression is influenced by tumour purity and fibroblast infiltration.

2019-07-20 | GSE134563 | GEO

Expression profile of Hepatocellular Carcinoma

Project description:Expression profiling of tumor and adjacent non-tumorous tissues of Hepatocellular Carcinoma (HCC) patients. Illumina HumanHT-12 V4.0 expression beadchip was used to obtain expression profiles across more than 31,000 annotated genes. Samples included 59 tumors and 59 adjacent non-tumorous samples. Total RNA obtained from the 39 tumors and 39 adjacent non-tumorous samples

2014-12-10 | E-GEOD-57957 | biostudies-arrayexpress

Immunosuppressive inflammation driven by LPS/TLR4 signalling in hepatocellular carcinoma with low immune cell infiltration

Project description:Immunosuppressive inflammation driven by LPS/TLR4 signalling in hepatocellular carcinoma with low immune cell infiltration

| PRJNA1044414 | ENA

Methylation profile of Hepatocellular Carcinoma

Project description:DNA methylation profiling of tumor and adjacent non-tumorous tissues of Hepatocellular Carcinoma (HCC) patients. The Illumina Infinium 27k Human DNA methylation Beadchip v1.2 was used to obtain DNA methylation profiles across approximately 27,000 CpGs. Samples included 59 tumors and 59 adjacent non-tumorous samples. Bisulphite converted DNA from the 59 tumors and 59 adjacent non-tumorous samples were hybridised to the Illumina Infinium 27k Human Methylation Beadchip.

2014-12-10 | E-GEOD-57956 | biostudies-arrayexpress

Expression profile of hepatocellular carcinoma-matrix interaction

Project description:Scirrous hepatocellular carcinoma is a rare type of liver tumor that is charecterized by fibrous stroma, biliary differentiation of tumor cells, and poorer prognosis. In this study, we aim to analyze the efefcts of collagen 1 on signal tranduction pathway activation, gene expression profile, and phenotypic changes of hepatocellular carcinoma.

2021-06-08 | GSE176270 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data